Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gastrointestinal Tolerability”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT07063823
What this trial is testing

A First-in-human Study to Evaluate the Safety and Tolerability of HB-2121 as a Diagnostic for Celiac Disease

Who this might be right for
Celiac DiseaseHealthy
Nielsen Fernandez-Becker 18
Not applicableTemporarily pausedNCT05079568
What this trial is testing

Evaluate the Safety and Tolerability of Virtual Reality to Treat Gastroparesis

Who this might be right for
Gastroparesis
Mayo Clinic 30
Testing effectiveness (Phase 2)Ended earlyNCT03329885
What this trial is testing

Experimental Medication BMS-986251, Taken by Mouth, in Healthy Participants and Patients With Average to Very Serious Psoriasis

Who this might be right for
Rheumatoid ArthritisPsoriasisAnkylosing Spondylitis+2 more
Bristol-Myers Squibb 38
Early research (Phase 1)Study completedNCT03411915
What this trial is testing

XmAb®18087 in Subjects With NET and GIST

Who this might be right for
Neuroendocrine TumorGastrointestinal Neoplasm
Xencor, Inc. 62
Early research (Phase 1)Ended earlyNCT07052682
What this trial is testing

Evaluate How Ontamalimab Works and Assess Its Safety and Tolerability in People With Nonalcoholic Steatohepatitis With Fibrosis Stages 1 to 4

Who this might be right for
Steatohepatitis
Takeda 11
Testing effectiveness (Phase 2)Study completedNCT01938625
What this trial is testing

Pharmacokinetics, Efficacy, Safety, Tolerability, of the Combination of Simeprevir (TMC435), Daclatasvir (BMS-790052), and Ribavirin (RBV) in Patients With Recurrent Chronic Hepatitis C Genotype 1b Infection After Orthotopic Liver Transplantation

Who this might be right for
Hepatitis C, Chronic
Janssen R&D Ireland 35
Early research (Phase 1)Ended earlyNCT03621982
What this trial is testing

Study of ADCT-301 in Patients With Selected Advanced Solid Tumors

Who this might be right for
Head and Neck Cancer Squamous Cell CarcinomaNon-small Cell Lung CancerGastric Cancer+9 more
ADC Therapeutics S.A. 78
Early research (Phase 1)Study completedNCT01590641
What this trial is testing

A Study Evaluating GS-9620 in Treatment Naive Subjects With Chronic Hepatitis B

Who this might be right for
Hepatitis BHBV
Gilead Sciences 49
Testing effectiveness (Phase 2)Study completedNCT00055367
What this trial is testing

Safety, Tolerability and Effectiveness of Natalizumab in Adolescents With Active Crohn's Disease

Who this might be right for
Crohn's Disease
Biogen 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07619898
What this trial is testing

PHOENIX-ECP- Extracorporeal Photopheresis for Immune-related Colitis and/or Hepatitis in Advanced Melanoma With Inadequate Response to Steroid Exposure

Who this might be right for
ColitisHepatitisMelanoma (Skin Cancer)
Therakos LLC 112
Testing effectiveness (Phase 2)Study completedNCT04401800
What this trial is testing

Preliminary Antitumor Activity, Safety and Tolerability of Tislelizumab in Combination With Lenvatinib for Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaUnresectable Hepatocellular CarcinomaMetastatic Hepatocellular Carcinoma
BeiGene 64
Early research (Phase 1)UnknownNCT05517564
What this trial is testing

First-in-Human Study of GM-60106 in Healthy Adults and Otherwise Healthy Adults With an Increased Body Mass Index and Markers of Non-Alcoholic Fatty Liver Disease

Who this might be right for
Non-alcoholic Steatohepatitis
JD Bioscience Inc. 96
Early research (Phase 1)Study completedNCT02310464
What this trial is testing

Trial of Active Immunotherapy With OBI-833 (Globo H-CRM197) in Advanced/Metastatic Gastric, Lung, Colorectal or Breast Cancer Subjects

Who this might be right for
Metastatic Gastric CancerMetastatic Breast CancerMetastatic Colorectal Cancer+1 more
OBI Pharma, Inc 25
Early research (Phase 1)Study completedNCT01227603
What this trial is testing

Single Dose Bioequivalence Study Comparing Nifedipine/Candesartan FDC (Fixed Dose Combination) With Loose Combination of Nifedipine GITS (Gastro-intestinal Therapeutic System) Plus Candesartan and Single Components Under Fasting Conditions

Who this might be right for
Hypertension, Essential
Bayer 49
Early research (Phase 1)Looking for participantsNCT07024641
What this trial is testing

Assess the Safety, Tolerability, and Pharmacokinetics of GIGA-2339 in Participants With Chronic Hepatitis B Virus Infection

Who this might be right for
Hepatitis B Virus Infection
GigaGen, Inc. 48
Testing effectiveness (Phase 2)Study completedNCT01161602
What this trial is testing

Evaluate the Safety, Tolerability and Pharmacodynamics of Pumosetrag in Patients With Gastroesophageal Reflux Disease (GERD)

Who this might be right for
Gastroesophageal Reflux Disease
Edusa Pharmaceuticals, Inc.
Testing effectiveness (Phase 2)Active Not RecruitingNCT05632939
What this trial is testing

ASKB589 in Combination With CAPOX and PD-1 Inhibitors in Patients With Advanced, and Unresectable G/GEJ Cancer.

Who this might be right for
Gastric CancerGastroesophageal Cancer (GC)
AskGene Pharma, Inc. 62
Not applicableActive Not RecruitingNCT07104877
What this trial is testing

SYS6010 in Combination With SYH2051 in Patients With Advanced Colorectal Cancer and Other Gastrointestinal Tumors

Who this might be right for
Colorectal CancerGastric Cancer (GC)Gastrointestinal Tumors
Fujian Cancer Hospital 25
Early research (Phase 1)UnknownNCT05393986
What this trial is testing

Claudin18.2-redirected Chimeric Antigen Receptor T Cells With Co-expression of Cytokines in Solid Tumors

Who this might be right for
Gastric AdenocarcinomaPancreatic CancerGastroesophageal Junction Adenocarcinoma
Peking University 63
Early research (Phase 1)Study completedNCT02108639
What this trial is testing

To Assess the Effect of Renal Impairment on the Blood Levels of Daclatasvir (DCV), Asunaprevir (ASV) and BMS-791325 After Multiple Doses of a Fixed Dose Combination Tablet

Who this might be right for
Hepatitis C
Bristol-Myers Squibb 41
Next Page